SAN DIEGO, April 18, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Climacteric, the official journal of the International ...
SAN DIEGO, March 16, 2026 (GLOBE NEWSWIRE)-- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science ...
Daré Bioscience Inc. (Nasdaq: DARE), a leader in innovation for the health and wellbeing of women, and the $4B federal health agency ARPA-H visit the Nasdaq MarketSite in Times Square. At the close of ...
Daré Bioscience is gathering steam—the women’s health player snapped up a microchip-based implant that could become a programmable, long-term contraceptive tool and unveiled positive data for its ...
DARE-HRT1 has the potential to be the first FDA-approved monthly intravaginal ring delivering both estrogen and progestogen hormone therapy SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience ...
DARE-HRT1 has the potential to be the first FDA-approved monthly intravaginal ring delivering both estrogen and progestogen hormone therapy SAN DIEGO, April 18, 2023 (GLOBE NEWSWIRE) -- Daré ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results